Timothy Alexander

ArriVent to Present Preclinical Cancer Drug Data at AACR 2026 NEWTOWN SQUARE, PA — ArriVent BioPharma Inc. (Nasdaq: AVBP) will present preclinical data on two cancer drug candidates at the American Association f […]

Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) reported higher fourth-quarter and full-year 2025 revenue, narrowed its losses, posted positive o […]

Prelude Therapeutics to Present Breast Cancer Drug Data at AACR 2026 WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) will present preclinical data on its experimental breast cancer drug candidate at t […]

Pennsylvania Horse Racing Association Announces 2026 Event Schedule HARRISBURG, PA — The Pennsylvania Horse Racing Association announced key dates for major horse racing events across the state in 2026, highlighting r […]

WHYY To Honor Malala Yousafzai With Lifelong Learning Award PHILADELPHIA, PA — WHYY will honor Nobel Peace Prize laureate Malala Yousafzai with its Lifelong Learning Award on Tuesday, April 14, 2026, at 5:30 p […]

Vasco Electronics Launches Web-Based Translation Platform WILMINGTON, DE — Vasco Electronics announced the launch of Vasco Audience, a web-based platform that provides simultaneous translation and live t […]

Vertex Makes Tax Software Available on Oracle Marketplace KING OF PRUSSIA, PA — Vertex Inc. (Nasdaq: VERX) said Tuesday its Vertex O Series Tax Engine and Indirect Tax Accelerator for Oracle enterprise r […]

Neuronetics Appoints Dan Reuvers as CEO, Succeeding Keith Sullivan MALVERN, PA — Neuronetics Inc. (Nasdaq: STIM) said it has appointed Dan Reuvers as president and chief executive officer, effective Monday, s […]

NRx Says FDA Finds No Bioequivalence Issues in Ketamine Filing WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) said the U.S. Food and Drug Administration has not identified bioequivalence deficiencies in i […]

Mineralys Grants Inducement Equity Awards to New Employee RADNOR, PA — Mineralys Therapeutics Inc. (Nasdaq: MLYS) said it granted stock options and restricted stock units to a new non-executive employee on M […]

The Lake That Covers a Town and Reveals a Story The surface of Marsh Creek Lake looks almost too calm in the early morning—just a slight ripple where a kayak cuts across the water, the paddle d […]

BTCS Revises 2026 Incentive Plan to Emphasize Profitability WAYNE, PA — BTCS Inc. (Nasdaq: BTCS) said it has revised its 2026 annual performance incentive program to place greater emphasis on gross profit, s […]

Aprea Reports 2025 Results, Early Data for APR-1051 Trial DOYLESTOWN, PA — Aprea Therapeutics Inc. (Nasdaq: APRE) reported its fourth-quarter and full-year 2025 financial results and said early clinical data f […]

Annovis Reports 2025 Results, Advances Buntanetap Trials MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) reported its 2025 financial results and said it advanced late-stage clinical development of its i […]

European Patent Office Grants Palvella Patent for QTORIN Rapamycin WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) said the European Patent Office has granted a patent covering its lead product candidate QTORIN 3 […]

TCHS Brandywine Students Earn First-Ever Tech Comp Victory DOWNINGTOWN, PA — Technical College High School Brandywine students captured their first-ever Greater Philadelphia Auto Technology Competition title, w […]

Medicus Pharma to Host Business Update Call Featuring Clinical Investigator PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) announced it will host a business update webcast on Thursday, March 26, at 11:30 a.m. Eastern t […]

NRx Says FDA Will Review NRX-100 Without New Trials WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) said it has received written confirmation from the U.S. Food and Drug Administration s […]

Where the Forest Grew Back Stronger The trail bends just enough to lose sight of the road, and with it, the last trace of noise. Leaves crunch underfoot—dry in places, damp in o […]

FDA Expands GSK RSV Vaccine Use to At-Risk Adults Ages 18–49 PHILADELPHIA, PA — GSK plc (NYSE: GSK) said the U.S. Food and Drug Administration has expanded approval of its RSV vaccine AREXVY to include adults a […]